NCT05839288View on ClinicalTrials.gov

Pyrotinib Plus Trastuzumab and Chemotherapy in HER2+ Metastatic Breast Cancer Patients

CompletedOBSERVATIONAL

Enrollment

161

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

April 1, 2023

Conditions

Breast Cancer

Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER